Average Co-Inventor Count = 4.24
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (27 from 3,681 patents)
2. Bristol-myers Squibb Pharma Company (12 from 234 patents)
3. Ariad Pharmaceuticals, Inc. (3 from 69 patents)
4. Dupont Pharmaceuticals Company (2 from 106 patents)
5. Bristol-myers Squibb Pharma Corporation (2 from 10 patents)
6. Other (1 from 832,680 patents)
7. Ono Pharmaceutical Co., Ltd. (574 patents)
47 patents:
1. 12473290 - Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
2. 12365667 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
3. 12110290 - Triazolopyridinyl compounds as kinase inhibitors
4. 11787779 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
5. 11767322 - Triazolopyridinyl compounds as kinase inhibitors
6. 11701373 - Substituted bicyclic compounds
7. 11597721 - Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responses
8. 11058696 - Substituted bicyclic compounds
9. 11021462 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
10. 10781215 - Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
11. 10709719 - Substituted bicyclic compounds
12. 10633339 - Tricyclic sulfone compound as a ROR gamma modulator
13. 10435369 - Tricyclic sulfones as ROR gamma modulators
14. 10294256 - Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses
15. 10166249 - Substituted bicyclic compounds